Results of European pooled analysis of IORT-containing multimodality treatment for locally advanced rectal cancer: Adjuvant chemotherapy prevents local recurrence rather than distant metastases

Annals of Oncology

Volumn 21, Issue 6, 2009, Pages 1279-1284

  Kusters, M ^a   Valentini, V ^b   Calvo, F A ^c   Krempien, R ^d   Nieuwenhuijzen, G A ^a   Martijn, H ^a   Doglietto, G B ^b   del Valle, E ^c   Roeder, F ^d   Buchler, M W ^d   van de Velde, C J H ^e   Rutten, H J T ^a  

^a CATHARINA HOSPITAL   (Netherlands)

^b CATHOLIC UNIVERSITY   (Italy)

^c HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^d UNIVERSITY OF HEIDELBERG   (Germany)

^e LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Chemotherapy; Intraoperative radiotherapy; Locally advanced rectal carcinoma; Multimodality treatment

Indexed keywords

FLUOROURACIL;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER RECURRENCE; CANCER REGRESSION; CANCER STAGING; CANCER SURGERY; EUROPE; FEMALE; HUMAN; INTRAOPERATIVE RADIOTHERAPY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MULTIMODALITY CANCER THERAPY; OVERALL SURVIVAL; POSTOPERATIVE CARE; PREOPERATIVE CARE; PRIORITY JOURNAL; RECTUM CANCER; RECURRENT CANCER; RISK FACTOR; ABDOMINAL SURGERY; ADJUVANT CHEMOTHERAPY; CARCINOMA; DISEASE COURSE; EPIDEMIOLOGY; INTRAOPERATIVE PERIOD; META ANALYSIS; METASTASIS; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; NEOPLASM RECURRENCE, LOCAL; PATHOLOGY; PROCEDURES; PROGNOSIS; RADIOTHERAPY; RECTAL NEOPLASMS; SURVIVAL; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; DIGESTIVE SYSTEM SURGICAL PROCEDURES; DISEASE PROGRESSION; EUROPE; FEMALE; HUMANS; INTRAOPERATIVE PERIOD; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; RADIOTHERAPY; RECTAL NEOPLASMS; SURVIVAL ANALYSIS;

EID: 77953965474     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdp501     Document Type: Article

References (19)

1. Heald RJ, Ryall RD. Recurrence and survival after total mesorectal excision for rectal cancer. Lancet 1986; 1(8496): 1479-1482.
2. Nagtegaal ID, van de Velde CJ, van der WE et al. Macroscopic evaluation of rectal cancer resection specimen: clinical significance of the pathologist in quality control. J Clin Oncol 2002; 20(7): 1729-1734.
3. Nagtegaal ID, Quirke P. What is the role for the circumferential margin in the modern treatment of rectal cancer? J Clin Oncol 2008; 26(2): 303-312.
4. Gunderson LL. Past, present, and future of intraoperative irradiation for colorectal cancer. Int J Radiat Oncol Biol Phys 1996; 34(3): 741-744.
5. Braendengen M, Tveit KM, Berglund A et al. Randomized phase III study comparing preoperative radiotherapy with chemoradiotherapy in nonresectable rectal cancer. J Clin Oncol 2008; 26(22): 3687-3694.
6. Mannaerts GH, Martijn H, Crommelin MA et al. Feasibility and first results of multimodality treatment, combining EBRT, extensive surgery, and IOERT in locally advanced primary rectal cancer. Int J Radiat Oncol Biol Phys 2000; 47(2): 425-433.
7. Taal BG, Van Tinteren H, Zoetmulder FA. Adjuvant 5FU plus levamisole in colonic or rectal cancer: improved survival in stage II and III. Br J Cancer 2001; 85(10): 1437-1443.
8. Quasar Collaborative Group, Gray R, Barnwell J et al. Adjuvant chemotherapy versus observation in patients with colorectal cancer: a randomised study. Lancet 2007; 370(9604): 2020-2029.
9. Diaz-Gonzalez JA, Calvo FA, Cortes J et al. Prognostic factors for disease-free survival in patients with T3-4 or N+ rectal cancer treated with preoperative chemoradiation therapy, surgery, and intraoperative irradiation. Int J Radiat Oncol Biol Phys 2006; 64(4): 1122-1128.
10. Valentini V, Coco C, Cellini N et al. Ten years of preoperative chemoradiation for extraperitoneal T3 rectal cancer: acute toxicity, tumor response, and sphincter preservation in three consecutive studies. Int J Radiat Oncol Biol Phys 2001; 51(2): 371-383.
11. Roeder F, Treiber M, Oertel S et al. Patterns of failure and local control after intraoperative electron boost radiotherapy to the presacral space in combination with total mesorectal excision in patients with locally advanced rectal cancer. Int J Radiat Oncol Biol Phys 2007; 67(5): 1381-1388.
12. Gosens MJ, Klaassen RA, Tan-Go I et al. Circumferential margin involvement is the crucial prognostic factor after multimodality treatment in patients with locally advanced rectal carcinoma. Clin Cancer Res 2007; 13(22 Pt 1): 6617-6623.
13. den Dulk M, Collette L, van de Velde C et al. Quality of surgery in T3-4 rectal cancer: involvement of circumferential resection margin not influenced by preoperative treatment. Results from EORTC trial 22921. Eur J Cancer 2007; 43(12): 1821-1828.
14. Mathis KL, Nelson H, Pemberton JH et al. Unresectable colorectal cancer can be cured with multimodality therapy. Ann Surg 2008; 248(4): 592-598.
15. Collette L, Bosset JF, den Dulk M et al. Patients with curative resection of cT3-4 rectal cancer after preoperative radiotherapy or radiochemotherapy: does anybody benefit from adjuvant fluorouracil-based chemotherapy? A trial of the European Organisation for Research and Treatment of Cancer Radiation Oncology Group. J Clin Oncol 2007; 25(28): 4379-4386.
16. Bosset JF, Collette L, Calais G et al. Chemotherapy with preoperative radiotherapy in rectal cancer. N Engl J Med 2006; 355(11): 1114-1123.
17. Calvo FA, Gomez-Espi M, Diaz-Gonzalez JA et al. Intraoperative presacral electron boost following preoperative chemoradiation in T3-4Nx rectal cancer: initial local effects and clinical outcome analysis. Radiother Oncol 2002; 62(2): 201-206.
18. Krempien R, Roeder F, Oertel S et al. Long-term results of intraoperative presacral electron boost radiotherapy (IOERT) in combination with total mesorectal excision (TME) and chemoradiation in patients with locally advanced rectal cancer. Int J Radiat Oncol Biol Phys 2006; 6(4): 1143-1151.
19. Kusters M, Holmans FA, Martijn H et al. Patterns of local recurrence in locally advanced rectal cancer after intra-operative electron radiation therapy containing multimodality treatment. Radiother Oncol 2009; 9(2): 221-225.